1-9 of 9
Reuben Harris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO5-27-03: Mutational impact of APOBEC3A and APOBEC3B in a human cell line

Free
Michael Carpenter, Nuri Temiz, Mahmoud Ibrahim, Matthew Jarvis, Margaret Brown, Prokopios Argyris, William Brown, Douglas Yee, Reuben Harris
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO5-27-03.
https://doi.org/10.1158/1538-7445.SABCS23-PO5-27-03
Published: 02 May 2024
View articletitled, Abstract PO5-27-03: Mutational impact of APOBEC3A and APOBEC3B in a human cell line
Journal Articles

Abstract P2-17-01: Targeted CRISPR screen to identify synthetic lethal combinations between APOBEC3B and DNA repair

Free
Bojana Stefanovska, Kevin Lin, Benjamin Troness, Chad Myers, Reuben Harris
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P2-17-01.
https://doi.org/10.1158/1538-7445.SABCS22-P2-17-01
Published: 01 March 2023
View articletitled, Abstract P2-17-01: Targeted CRISPR screen to identify synthetic lethal combinations between APOBEC3B and DNA repair
Journal Articles

An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations

Available to Purchase
Jesse Boumelha, Sophie de Carné Trécesson, Emily K. Law, Pablo Romero-Clavijo, Matthew A. Coelho, Kevin W. Ng, Edurne Mugarza, Christopher Moore, Sareena Rana, Deborah R. Caswell, Miguel Murillo, David C. Hancock, Prokopios P. Argyris, William L. Brown, Cameron Durfee, Lindsay K. Larson, Rachel I. Vogel, Alejandro Suárez-Bonnet, Simon L. Priestnall, Philip East, Sarah J. Ross, George Kassiotis, Miriam Molina-Arcas, Charles Swanton, Reuben Harris, Julian Downward
Journal: Cancer Research
Cancer Res (2022) 82 (19): 3435–3448.
https://doi.org/10.1158/0008-5472.CAN-22-0325
Published: 04 October 2022
View articletitled, An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations
Open the PDF for An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations in another window
Includes: Supplementary data
Journal Articles

Abstract PD1-06: Apobec mutagenesis is a pervasive feature of poor prognosis breast cancer associating with ESR1 wild type, endocrine resistant disease

Free
Antonio Marra, Andrea Gazzo, Pier Selenica, Xin Pei, Avantika Gupta, Fresia Pareja, Giuseppe Curigliano, Reuben Harris, Nadeem Riaz, Jorge S. Reis-Filho, Sarat Chandarlapaty
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD1-06.
https://doi.org/10.1158/1538-7445.SABCS21-PD1-06
Published: 15 February 2022
View articletitled, Abstract PD1-06: Apobec mutagenesis is a pervasive feature of poor prognosis breast cancer associating with ESR1 wild type, endocrine resistant disease
Journal Articles

Abstract P5-01-10: A panel of murine mammary tumor cell lines to study immune responses to epitopes created by different mutagens including human APOBEC3 enzymes

Free
Jordan Naumann, Michael Carpenter, Prokopios Argyris, William Brown, Reuben Harris
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-01-10.
https://doi.org/10.1158/1538-7445.SABCS21-P5-01-10
Published: 15 February 2022
View articletitled, Abstract P5-01-10: A panel of murine mammary tumor cell lines to study immune responses to epitopes created by different mutagens including human APOBEC3 enzymes
Journal Articles

Abstract LB124: APOBEC3B fuels evolution of resistance during targeted cancer therapy

Free
Manasi K. Mayekar, Deborah Caswell, Natalie Vokes, Wei Wu, Caroline McCoach, Collin Blakely, Nuri Alpay Temiz, Daniel Lucas Kerr, Julia Rotow, Franziska Haderk, Lauren Cech, Beatrice Gini, Shigeki Nanjo, Lisa Tan, Johnny Yu, Carlos Gomez, Philippe Gui, Elizabeth Yu, Nicholas Thomas, Julian Downward, Reuben Harris, Eliezer Van Allen, Charles Swanton, Trever Bivona
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB124.
https://doi.org/10.1158/1538-7445.AM2021-LB124
Published: 01 July 2021
View articletitled, Abstract LB124: APOBEC3B fuels evolution of resistance during targeted cancer therapy
Journal Articles

Abstract 2938: APOBEC3B and TKI resistance in EGFR mutant lung cancer

Free
Deborah Caswell, Manasi Mayekar, Emily Law, William Hill, Eva Gronroos, Reuben Harris, Trever Bivona, Charles Swanton
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2938.
https://doi.org/10.1158/1538-7445.AM2021-2938
Published: 01 July 2021
View articletitled, Abstract 2938: APOBEC3B and TKI resistance in EGFR mutant lung cancer
Journal Articles

Abstract 295: The cytosine deaminase APOBEC3B affects responses to therapy in estrogen receptor positive breast cancer cells

Free
Kelly S. LaPara, Emily Law, Reuben Harris, Douglas Yee
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 295.
https://doi.org/10.1158/1538-7445.AM2016-295
Published: 15 July 2016
View articletitled, Abstract 295: The cytosine deaminase APOBEC3B affects responses to therapy in estrogen receptor positive breast cancer cells
Journal Articles

Abstract LB-193: APOBEC3 catalyzed genomic mutations in breast cancer

Free
Michael B. Burns, Lela Lackey, Allison Land, Anurag Rathore, Eric Refsland, Reuben Harris
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): LB-193.
https://doi.org/10.1158/1538-7445.AM2011-LB-193
Published: 15 April 2011
View articletitled, Abstract LB-193: APOBEC3 catalyzed genomic mutations in breast cancer